BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8050912)

  • 1. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of radioimmunotherapy of head and neck cancer.
    Gerretsen M; Quak JJ; Brakenhoff RH; Snow GB; van Dongen GA
    Eur J Cancer B Oral Oncol; 1994; 30B(2):82-7. PubMed ID: 8032305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
    Quak J; van Dongen G
    Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control of radiolabeled monoclonal antibodies.
    Khazaeli MB
    Cancer Biother Radiopharm; 2000 Dec; 15(6):529-30. PubMed ID: 11190485
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploration of novel strategies to enhance monoclonal antibodies targeting.
    Khawli LA; Epstein AL
    Q J Nucl Med; 1997 Mar; 41(1):25-35. PubMed ID: 9195850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013).
    Peña Y; Perera A; Batista JF
    MEDICC Rev; 2014; 16(3-4):55-60. PubMed ID: 25208121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunodetection and radioimmunotherapy of breast cancer.
    Riva P; Franceschi G; Gentile R; Riva N; Casi M
    Tumori; 1997; 83(2):552-7. PubMed ID: 9226019
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.
    Brouwers AH; Buijs WC; Oosterwijk E; Boerman OC; Mala C; De Mulder PH; Corstens FH; Mulders PF; Oyen WJ
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3953S-60S. PubMed ID: 14506194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunodiagnosis and therapy.
    Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
    Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.
    Gripp FM; Quak J; Leverstein H; Schrijvers A; Gerretsen M; Brakenhoff R; Van Dongen G; Snow GB; Rapoport A
    Sao Paulo Med J; 1994; 112(3):612-21. PubMed ID: 7638523
    [No Abstract]   [Full Text] [Related]  

  • 12. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
    Larson SM
    Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretargeting strategies for radio-immunoguided tumour localisation and therapy.
    Stoldt HS; Aftab F; Chinol M; Paganelli G; Luca F; Testori A; Geraghty JG
    Eur J Cancer; 1997 Feb; 33(2):186-92. PubMed ID: 9135486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of radioimmunotherapy for hematologists and oncologists.
    Press OW; Rasey J
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):62-73. PubMed ID: 11226002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.
    Fleckenstein G; Osmers R; Puchta J
    Med Oncol; 1998 Dec; 15(4):212-21. PubMed ID: 9951683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
    Zalutsky MR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1958-60. PubMed ID: 16609003
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour imaging with radiolabelled monoclonal antibodies.
    Britton KE
    Wien Klin Wochenschr; 1994; 106(2):35-6. PubMed ID: 8146993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
    Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
    Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.
    Divgi CR
    Oncology (Williston Park); 1996 Jun; 10(6):939-53; discussion 954, 957-8. PubMed ID: 8823804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.